2. Gene
  3. C3 - complement C3 Gene

C3 - complement C3 Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Macaca fascicularis

基因 ID: 102131458 | 基因类型: protein coding

关于 C3

C3 基因产物(1)

mRNA Protein Name
XM_005587719.3 XP_005587776.2 complement C3
蛋白主名 其他名称

complement C3

重组 C3 蛋白

目录号 产品名 蛋白编号 纯度
HY-P75332 Complement C3 Protein, Cynomolgus (HEK293, His) XP_005587776 (T23-N1663) ≥95%

相关产品

Approval
抗体抑制剂 (1)
目录号 产品名 作用方式
纯度 是否罕见病
HY-P99050 Sutimlimab Inhibitor 98.81% 否
Clinical Phase
生物活性分子 (15)
目录号 产品名 作用方式
纯度 Phase
HY-14605BS Rasagiline-13C3 mesylate racemic Inhibitor / Phase 4
HY-127105 Iptacopan Inhibitor 99.96% Phase 3
HY-106178 PMX-53 Antagonist 98.60% Phase 2
HY-P1717A AMY-101 TFA Inhibitor 99.89% Phase 2
HY-P1717B AMY-101 acetate Inhibitor 99.93% Phase 2
HY-19903 ASP-9521 Inhibitor ≥98.0% Phase 2
HY-P3204 POT-4 Inhibitor 99.64% Phase 2
HY-124573 OBI-3424 99.23% Phase 2
HY-P2141 TRV-120027 Agonist 99.46% Phase 2
HY-P2141A TRV-120027 TFA Agonist 99.69% Phase 2
HY-N9481 Lipoteichoic acid Activator / Phase 2
HY-P1717 AMY-101 Inhibitor / Phase 2
HY-108325A Brequinar sodium / Phase 2
HY-P3204A POT-4 TFA Inhibitor / Phase 2
HY-10819 AG2034 Inhibitor / Phase 1
抗体抑制剂 (2)
目录号 产品名 作用方式
纯度 Phase
HY-P990091 Riliprubart Inhibitor 99.90% Phase 3
HY-P990025 Empasiprubart 97.93% Phase 2
Pre-clinical Phase
生物活性分子 (534)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-101502A SB290157 trifluoroacetate Antagonist 99.87% 否
HY-12481 SAR405 Inhibitor 99.49% 否
HY-N0376 Liquiritin 99.68% 否
HY-112842 MBQ-167 Inhibitor 99.86% 否
HY-138161 JR14a Antagonist 99.59% 否
HY-P1036 Compstatin Inhibitor 99.76% 否
HY-132295 Azenosertib Inhibitor 99.96% 否
HY-Y0479AS L-Lactic acid-13C3 sodium ≥98.0% 否
HY-15976 P7C3 99.85% 否
HY-103007 TC-G-1008 Agonist 99.61% 否
HY-15978 P7C3-A20 98.97% 否
HY-125877 PROTAC Mcl1 degrader-1 Inhibitor 98.13% 否
HY-P2848 Cholesterol oxidase, Microorganism ≥90.0% 否
HY-128358 MR-L2 Activator 99.23% 否
HY-Y0479S L-Lactic acid-13C3 99.10% 否
HY-108568 15-Deoxy-Δ-12,14-prostaglandin J2 Agonist ≥99.0% 否
HY-112633 SMN-C3 Modulator 99.89% 是
HY-P1345A TLQP-21 TFA Agonist 99.90% 否
HY-128132 C3a receptor agonist 1 Agonist 98.04% 否
HY-W015913S Sodium 2-oxopropanoate-13C3 Inhibitor 99.7% 否
HY-138557 AKR1C3-IN-4 Inhibitor 99.77% 否
HY-134978 (Rac)-SHIN2 Inhibitor 99.40% 否
HY-N0650S L-Serine-13C3 98.20% 否
HY-N6978 Ascr#5 ≥98.0% 否
HY-147090 Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH Degrader 98.24% 否
HY-Y0337S L-Cysteine-13C3,15N 99.9% 否
HY-161022A FL118-C3-O-C-amide-C-NH2 formate 95.82% 否
HY-150644 S07-2010 Inhibitor 99.79% 否
HY-107379 AKR1C3-IN-1 Inhibitor 98.23% 否
HY-126521 N3-C3-NHS ester ≥98.0% 否
HY-133479 Tetrazine-Ph-NHCO-C3-NHS ester 98.28% 否
HY-B1337S4 Choline Chloride-13C3 99.69% 否
HY-P3252A Pegcetacoplan acetate Inhibitor 98.72% 否
HY-130142A Biotinyl-NH-PEG3-C3-amido-C3-COOH 99.91% 否
HY-140902A Biotin-PEG3-C3-NH2 ≥97.0% 否
HY-N10361 Drupanin 98.05% 否
HY-103612 Thalidomide-O-amido-C3-COOH Inducer 98.43% 否
HY-113248S1 3-Nitro-L-tyrosine-13C6 ≥95.0% 否
HY-133689AS 3-Nitrophenylhydrazine-13C6 hydrochloride 98.26% 否
HY-162266 C3TD879 Inhibitor 99.42% 否
HY-N1981S Triolein-13C3 Inhibitor 98.00% 否
HY-131011 Furanone C-30 Inhibitor ≥98.0% 否
HY-145127 ETZ 97.06% 否
HY-155035 S07-1066 Inhibitor 99.48% 否
HY-D1342 Coumberol 99.99% 否
HY-W422359A 2-Aminopurine-O-Ph-NHCO-C3-COOH hydrochloride 95.27% 否
HY-131185 Pomalidomide-amido-C3-COOH 99.51% 否
HY-100683 A12B4C3 Inhibitor 98.0% 否
HY-113128S sn-Glycerol 3-phosphate-13C3 disodium 98.7% 否
HY-133618 Pomalidomide-C3-adavosertib Degrader 99.84% 否
HY-135306 Cl-C6-PEG4-C3-COOH 99.65% 否
HY-152189 S19-1035 99.77% 否
HY-N0650S5 L-Serine-13C3,15N ≥99.0% 否
HY-W004701 Br-C3-methyl ester 98.61% 否
HY-W006057AS16 Sodium 3-methyl-2-oxobutanoate-13C5 99.00% 否
HY-Y0337S4 L-Cysteine-13C3 99.90% 否
HY-103608 (S,R,S)-AHPC-(C3-​PEG)​2-​C6-​Cl 99.89% 否
HY-108568S 15-Deoxy-Δ-12,14-prostaglandin J2-d4 Agonist 98.10% 否
HY-117992 BR103 99.75% 否
HY-130711B (S,R,S)-AHPC-C3-NH2 hydrochloride 96.38% 否
HY-B1659S5 Glycerol-13C3 99.10% 否
HY-N0322S4 Cholesterol-13C3 Agonist 98.80% 否
HY-N0680S3 Thiamine-13C3 hydrochloride 99.90% 否
HY-P1505A C3a (70-77) (TFA) 95.02% 否
HY-12481A SAR405 R enantiomer 99.94% 否
HY-145225 DLin-K-C3-DMA Chemical ≥98.0% 否
HY-128856 P7C3-OMe 98.26% 否
HY-140928 Biotin-PEG4-amino-t-Bu-DADPS-C3-alykne ≥95.0% 否
HY-148142 Pomalidomide-C3-NHS ester 98.70% 否
HY-152188 AKR1C3-IN-9 Inhibitor 99.37% 否
HY-161022S1 FL118-C3-O-C-amide-C-NH2-d5 formate / 否
HY-B1342S3 Retinol-13C3 95.71% 否
HY-N0136S1 (±)-Taxifolin-13C3 Inhibitor 99.63% 否
HY-R00006 hsa-let-7c-3p mimic 93.63% 否
HY-R00717 hsa-miR-34c-3p mimic 94.18% 否
HY-R01568 hsa-miR-518c-3p mimic 92.33% 否
HY-R01678 hsa-miR-548c-3p mimic 92.16% 否
HY-RI00407 hsa-miR-200c-3p inhibitor 94.62% 否
HY-W004640 N-Boc-C1-PEG3-C3-NH2 ≥98.0% 否
HY-115560A Thalidomide-O-amido-C3-NH2 TFA Inducer 99.58% 否
HY-131646 Thalidomide-O-amido-C3-PEG3-C1-NH2 Inducer 99.08% 否
HY-109154 Obafistat Inhibitor 99.92% 否
HY-P1036A Compstatin TFA Inhibitor 99.02% 否
HY-100196S1 Pyrroloquinoline quinone-13C3 sodium 99.29% 否
HY-113008AS cis-Urocanic acid-13C3 Agonist 99.46% 否
HY-120903 DBCO-C3-Acid ≥95.0% 否
HY-131455A Biotin-C1-PEG3-C3-amido-C5-Gly-Arg-Gly-N3 TFA ≥98.0% 否
HY-131888 Pomalidomide-C3-NH2 hydrochloride 95.38% 否
HY-138847A Thalidomide-4-O-C3-NH2 hydrochloride Inducer / 否
HY-139683 Antiviral agent 5 Chemical 98.93% 否
HY-144432S Vitamin B5-13C3,15N hemicalcium hemihydrate 99.7% 否
HY-150156 Anti-inflammatory agent 32 99.52% 否
HY-15129S O-Phospho-L-serine-13C3,15N Modulator 99.19% 否
HY-158118 Lys(CO-C3-p-I-Ph)-OMe 97.19% 否
HY-158122 Lys(CO-C3-p-I-Ph)-O-tBu 98.14% 否
HY-160897 Methoxy-PEG-C3-amide-C2-Mal 99.69% 否
HY-161022 FL118-C3-O-C-amide-C-NH2 / 否
HY-161022S FL118-C3-O-C-amide-C-NH2-d5 / 否
HY-40354S Tofacitinib-13C3 / 否
HY-B1773AS3 Propanoic-13C3 sodium / 否
HY-D1056C1 Lipopolysaccharides, from S. enterica serotype enteritidis Activator / 否
HY-N0437S2 Progesterone-13C3 Agonist 99.60% 否
HY-N0898S Catechin-13C3 98.06% 否
HY-N2362S1 DL-Alanine-13C-3 ≥98.0% 否
HY-N4134 Ciwujianoside C3 Inhibitor ≥98.0% 否
HY-N6685S1 3-Acetyldeoxynivalenol-13C17 ≥99.0% 否
HY-P1505 C3a (70-77) / 否
HY-R00840 hsa-miR-376c-3p mimic 93.13% 否
HY-RI00840 hsa-miR-376c-3p inhibitor 99.33% 否
HY-W010407S Cyanuric acid-13C3 ≥98.0% 否
HY-W010421S Ammelide-13C3 99.85% 否
HY-B0356AS1 Ciprofloxacin-13C3,15N monohydrochloride 99.9% 否
HY-W392808 Spacer phosphoramidite C3 ≥98.0% 否
HY-115560 Thalidomide-O-amido-C3-NH2 Inducer / 否
HY-130711A (S,R,S)-AHPC-C3-NH2 TFA / 否
HY-131876 Thalidomide-O-C3-acid Inducer / 否
HY-135900 Aniline-MPB-amino-C3-PBD Inhibitor / 否
HY-130711 (S,R,S)-AHPC-C3-NH2 / 否
HY-131186 Pomalidomide-amido-C3-piperazine-N-Boc / 否
HY-100582S2 Ribitol-3-13C / 否
HY-111297 BMVC4 / 否
HY-112251S D-Lin-MC3-DMA-13C3 / 否
HY-113008S1 Urocanic acid-13C3 / 否
HY-113357S m-Coumaric acid-13C3 / 否
HY-114773 N-Undecanoyl-L-homoserine lactone / 否
HY-115902 FGFR4-IN-7 / 否
HY-116021S Buquinolate-13C3 Inhibitor / 否
HY-116025 APN-C3-PEG4-alkyne / 否
HY-116084S1 Trimethylamine-N-oxide-13C3 Activator / 否
HY-117074 BMS-247243 / 否
HY-121412 Lankacidin C Inhibitor / 否
HY-121635 FOX-7 / 否
HY-12210 (S)-BI-1001 Inhibitor / 否
HY-12542S Dantrolene-13C3 Inhibitor ≥99.0% 否
HY-126287 JND4135 / 否
HY-128748S4 DL-Glyceraldehyde-13C3 / 否
HY-128753S4 D-Lyxose-13C-3 / 否
HY-129974S 3,3'-Diiodo-L-thyronine-13C6 / 否
HY-130142 Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA) / 否
HY-130585S Estradiol undecylate-13C3 / 否
HY-130711C (S,R,S)-AHPC-C3-NH2 dihydrochloride / 否
HY-131184 N-Boc-piperazine-C3-COOH / 否
HY-131190 N-Boc-SBP-0636457-O-C3-COOH / 否
HY-131800 3'-Deoxy-3'-amino-ATP / 否
HY-131888A Pomalidomide-C3-NH2 / 否
HY-133403A Biotin-C1-PEG3-C3-amine TFA / 否
HY-133584 Bis-SS-C3-NHS ester / 否
HY-133585 Bis-SS-C3-sulfo-NHS ester / 否
HY-133702 Aniline-piperazine-C3-NH-Boc / 否
HY-134679 N-Boc-C1-PEG5-C3-NH2 / 否
HY-134692 Azido-C1-PEG3-C3-NH2 / 否
HY-134693 Azido-C1-PEG4-C3-NH2 / 否
HY-134749 Propargyl-PEG2-urea-C3-triethoxysilane / 否
HY-135901 Py-MPB-amino-C3-PBD Inhibitor / 否
HY-13632S1 Exemestane-13C3 Inhibitor / 否
HY-136457S 2-NP-AHD-13C3 / 否
HY-13653S (+/-)-Epigallocatechin Gallate-13C3 / 否
HY-138847 Thalidomide-O-C3-NH2 Inducer / 否
HY-138850 Thalidomide-NH-amido-C3-NH2 Inducer / 否
HY-138850A Thalidomide-NH-amido-C3-NH2 hydrochloride Inducer / 否
HY-139145S Etbicyphat-13C3 / 否
HY-139427S 3-Methylglutaconic acid-13C3 / 否
HY-139545 Thalidomide-4-C3-NH2 hydrochloride Inducer / 否
HY-139721 Tenofovir-C3-O-C15-CF3 ammonium Inhibitor / 否
HY-139722 Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium Inhibitor / 否
HY-140019 Azido-PEG3-amide-C3-triethoxysilane / 否
HY-140288 DBCO-C3-PEG4-amine / 否
HY-140295 DBCO-C3-PEG4-NH-Boc / 否
HY-140347 APN-C3-NH-Boc / 否
HY-140478 Boc-NH-PEG4-C3-acid / 否
HY-140808 Azido-PEG3-C3-OH / 否
HY-140841 APN-C3-PEG4-azide 98.56% 否
HY-140902 rel-Biotin-PEG3-C3-NH2 / 否
HY-140927 Azido-C3-UV-biotin / 否
HY-141065 N-(azide-PEG3)-N'-(Amine-C3-Amide-PEG4)-Cy5 / 否
HY-141407 m-PEG3-amido-C3-triethoxysilane / 否
HY-141597 Acid-C3-SSPy / 否
HY-141651 (S,R,S)-AHPC-C3-COOH / 否
HY-141857S 5-(4-Hydroxyphenyl)-5-phenyl-d5-hydantoin-2,4,5-13C3 / 否
HY-141893 3-Cyanovinylcarbazole phosphoramidite Inhibitor / 否
HY-141901S2 Dehydroepiandrosterone-13C3 / 否
HY-141907S 17β-Estradiol-13C3 / 否
HY-142140S 3-epi-25-Hydroxy Vitamin D3-d6 / 否
HY-143342 LEB-03-144 / 否
HY-143400 HSP70-IN-3 Inhibitor / 否
HY-143439 LX-039 Antagonist / 否
HY-144749 AKR1C3-IN-5 / 否
HY-145253 Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH Inhibitor / 否
HY-145254 Tri(TLR4-IN-C34-PEG2-amide-PEG1)-amide-C3-COOH Inhibitor / 否
HY-145255 Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH Inhibitor / 否
HY-14605S Rasagiline-13C3 mesylate / 否
HY-146573 AKR1C3-IN-6 Inhibitor / 否
HY-146574 AKR1C3-IN-7 Inhibitor / 否
HY-146575 AKR1C3-IN-8 Inhibitor / 否
HY-148460 Mal-VC-PAB-(N-Me-amide-C3)-ADU-S100 triethylamine / 否
HY-148471A C3-Amide-C4-NH2 / 否
HY-149749 Methylthiomcresol-C3-COOH / 否
HY-150624 SARS-CoV-2 nsp13-IN-3 Inhibitor / 否
HY-150646 S07-2009 / 否
HY-150648 S07-2008 Inhibitor / 否
HY-150649 S07-2005 (racemic) / 否
HY-150650 S07-2001 / 否
HY-15097S Myricetin-13C3 Inducer / 否
HY-153456 Hedgehog IN-2 Inhibitor / 否
HY-15398S1 Vitamin D3-13C3 Activator / 否
HY-155259 Pomalidomide-5-C3-NH2 hydrochloride 96.02% 否
HY-155502 AKR1C3-IN-10 Inhibitor / 否
HY-155716 G43-C3-TEG Inhibitor / 否
HY-156086 TRK-IN-24 Inhibitor / 否
HY-157510 Thalidomide-O-C3-azide / 否
HY-157810 AKR1C3-IN-11 Inhibitor / 否
HY-158383 Pomalidomide-CO-C3-PEG4-C6-NH2 / 否
HY-158732 MAO-B-IN-33 Inhibitor / 否
HY-159604 METTL3-IN-9 Inhibitor / 否
HY-15977 (S)-P7C3-OMe / 否
HY-161131 Lenalidomide 4'-alkyl-C3-azide / 否
HY-161468 Thalidomide-N-C3-O-C4-O-C3-OH Inducer / 否
HY-161653 Boc-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione / 否
HY-161708 PROTAC FLT3/CDKs degrader-1 Degrader / 否
HY-161832 (S,R,S)-Me-AHPC-amide-C3-alkyne / 否
HY-161839 AKR1C2/3-IN-1 Inhibitor / 否
HY-161929 GPX4 activator 2 / 否
HY-162714 C3N-Dbn-Trp2 Inhibitor / 否
HY-162816 PROTAC HPK1 Degrader-3 / 否
HY-163223 (S,R,S)-AHPC-CO-CH2-piperazine-C3-piperazine-Boc / 否
HY-163267 ZNL0325 / 否
HY-163323 AKR1C3-IN-12 Inhibitor / 否
HY-163609 PROTAC AKR1C3 degrader-1 Degrader / 否
HY-163610 AKR1C3-IN-13 Inhibitor / 否
HY-163678 Pomalidomide-CO-C7-NH-CO-C3-COOH / 否
HY-163758 COOH-C3-CONH-C7-COOH / 否
HY-163784 AKR1C3-IN-14 Inhibitor / 否
HY-163821 HO-CONH-C3-PEG3-NH2 / 否
HY-163903 OH-C2-PEG3-NHCO-C3-COOH / 否
HY-163904 (S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH / 否
HY-163940 LX1 Inhibitor / 否
HY-163962 L18I / 否
HY-163964 Lenalidomide-C3-PEG3-N3 / 否
HY-164085 Azide-C3-NHCO-C3-NHS ester / 否
HY-17461S Cortisone-13C3 Agonist / 否
HY-18085S2 Quercetin-13C3 / 否
HY-19717S DCVC-13C3,15N / 否
HY-23506S 1-Aminoimidazolidine-2,4-dione-13C3 / 否
HY-32351B 3-epi-Calcifediol / 否
HY-34628S1 Tri-O-acetyl-D-glucall-13C-1 / 否
HY-34628S2 Tri-O-acetyl-D-glucal-13C-2 / 否
HY-79395S1 Dimethyl carbonate-13C3 / 否
HY-A0090S Nitrofurantoin-13C3 / 否
HY-A0132S5 N-Acetyl-D-glucosamine-13C-3 / 否
HY-A0132S9 N-Acetyl-D-glucosamine-13C3,15N / 否
HY-A0253S Cefacetrile-13C3 / 否
HY-B0143S4 Niacin-15N,13C3 / 否
HY-B0150S1 Nicotinamide-15N,13C3 Inhibitor / 否
HY-B0166S4 L-Ascorbic acid-13C-3 / 否
HY-B0228S3 Adenosine-3′-13C / 否
HY-B0234S Estrone-13C3 Agonist / 否
HY-B0388S Probucol-13C3 Inhibitor / 否
HY-B0389S13 D-Glucose-13C-3 / 否
HY-B0389S18 D-Glucose-13C3-1 / 否
HY-B0389S9 D-Glucose-13C3-2 / 否
HY-B0412S3 Estriol-13C3 Antagonist / 否
HY-B0430S Pantothenic acid-13C3,15N hemicalcium / 否
HY-B0495S Lamotrigine-13C3,d3 / 否
HY-B0495S4 Lamotrigine-13C3 / 否
HY-B0510S3 Trimethoprim-13C3 / 否
HY-B0526S Flumequine-13C3 Inhibitor / 否
HY-B0891S1 17α-Hydroxyprogesterone-13C3 Agonist / 否
HY-B1075AS (Rac)-Fosfomycin (benzylamine)-13C3 / 否
HY-B1241A Dihydrostreptomycin / 否
HY-B1331S1 Cyromazine-13C3 / 否
HY-B1449S4 Uridine-13C-3 / 否
HY-B1659S Glycerol-13C3,d8 / 否
HY-B1732S1 DL-3-Phenylalanine-13C / 否
HY-D1516 NerveGreen C3 / 否
HY-D1558 1,3,5,7-Tetramethyl-2,6-diiodo-C3-SE-BODIPYs / 否
HY-D1581 BODIPY 505/515-8-C3-COOH / 否
HY-D2200 Cy5.5(Me)-C3-DBCO / 否
HY-I0400S3 N-Acetylneuraminic acid-13C-3 / 否
HY-N0001S (±)-Epicatechin-13C3 / 否
HY-N0055S Chlorogenic acid-13C3 / 否
HY-N0059S3 D-Arabinose-13C-3 / 否
HY-N0060S1 Ferulic acid-13C3 Inhibitor / 否
HY-N0086S3 N6-Methyladenosine-13C3 Inhibitor / 否
HY-N0172S Caffeic acid-13C3 Inhibitor / 否
HY-N0210S2 D-Galactose-13C-3 / 否
HY-N0229S10 L-Alanine-13C3,15N ≥98.0% 否
HY-N0229S5 L-Alanine-13C3,15N,d4 / 否
HY-N0229S8 L-Alanine-13C3 / 否
HY-N0230S β-Alanine-13C3,15N / 否
HY-N0351S p-Coumaric acid-13C3 / 否
HY-N0356S (+/-)-Catechin Gallate-13C3 Inhibitor / 否
HY-N0379S8 D-Mannose-13C-3 / 否
HY-N0382S Galangin-13C3 / 否
HY-N0464S Quinic acid-13C3 / 否
HY-N0521AS (+)-Gallocatechin-13C3 / 否
HY-N0537S5 Xylose-3-13C / 否
HY-N0610AS2 Cinnamic acid-13C3 99.91% 否
HY-N0650S3 L-Serine-13C3,15N,d3 / 否
HY-N0683S1 α-Vitamin E-13C3 Inhibitor / 否
HY-N0771S6 L-Cysteine-13C3,15N,d3 / 否
HY-N10263 Palmarumycin C3 / 否
HY-N10519 Cellooctaose / 否
HY-N10998 Chamaejasmenin A / 否
HY-N11646 Ganorbiformin B Inhibitor / 否
HY-N1428S3 Citric acid-13C3 / 否
HY-N1480S3 (-)-Fucose-13C-3 / 否
HY-N2041S4 Myristic acid-13C3 / 否
HY-N3205 Neochamaejasmin B / 否
HY-N7091S1 Atrazine-13C3,15N3 / 否
HY-N8847S α-Ionone-13C3 / 否
HY-N9332 Kalopanax saponin G / 否
HY-P1142S GLP-2(rat) (Ala-13C3,15N) / 否
HY-P1142S1 GLP-2(rat) (Ala-13C3,15N) (TFA) / 否
HY-P1345 TLQP-21 Agonist / 否
HY-P1640 (Trp63,Trp64)​-​C3a(63-77) Agonist / 否
HY-P2325 Exoenzyme C3, clostridium botulinum / 否
HY-P5071 EcAMP3 / 否
HY-R00006A hsa-let-7c-3p agomir / 否
HY-R00333 hsa-miR-181c-3p mimic / 否
HY-R00333A hsa-miR-181c-3p agomir / 否
HY-R00407 hsa-miR-200c-3p mimic / 否
HY-R00407A hsa-miR-200c-3p agomir / 否
HY-R00717A hsa-miR-34c-3p agomir / 否
HY-R00832 hsa-miR-374c-3p mimic / 否
HY-R00832A hsa-miR-374c-3p agomir / 否
HY-R00840A hsa-miR-376c-3p agomir / 否
HY-R01112 hsa-miR-449c-3p mimic / 否
HY-R01112A hsa-miR-449c-3p agomir / 否
HY-R01546 hsa-miR-513c-3p mimic / 否
HY-R01546A hsa-miR-513c-3p agomir / 否
HY-R01568A hsa-miR-518c-3p agomir / 否
HY-R01590 hsa-miR-519c-3p mimic / 否
HY-R01590A hsa-miR-519c-3p agomir / 否
HY-R01598 hsa-miR-520c-3p mimic / 否
HY-R01598A hsa-miR-520c-3p agomir / 否
HY-R01678A hsa-miR-548c-3p agomir / 否
HY-R02506 hsa-miR-892c-3p mimic / 否
HY-R02506A hsa-miR-892c-3p agomir / 否
HY-R02698 mmu-miR-181c-3p mimic / 否
HY-R02698A mmu-miR-181c-3p agomir / 否
HY-R02795 mmu-miR-1970c-3p mimic / 否
HY-R02795A mmu-miR-1970c-3p agomir / 否
HY-R02833 mmu-miR-216c-3p mimic / 否
HY-R02833A mmu-miR-216c-3p agomir / 否
HY-R02840 mmu-miR-219c-3p mimic / 否
HY-R02840A mmu-miR-219c-3p agomir / 否
HY-R02897 mmu-miR-302c-3p mimic / 否
HY-R02897A mmu-miR-302c-3p agomir / 否
HY-R03043 mmu-miR-344c-3p mimic / 否
HY-R03043A mmu-miR-344c-3p agomir / 否
HY-R03077 mmu-miR-34c-3p mimic / 否
HY-R03077A mmu-miR-34c-3p agomir / 否
HY-R03104 mmu-miR-374c-3p mimic / 否
HY-R03104A mmu-miR-374c-3p agomir / 否
HY-R03111 mmu-miR-376c-3p mimic / 否
HY-R03111A mmu-miR-376c-3p agomir / 否
HY-R03148 mmu-miR-449c-3p mimic / 否
HY-R03148A mmu-miR-449c-3p agomir / 否
HY-R03198 mmu-miR-467c-3p mimic / 否
HY-R03198A mmu-miR-467c-3p agomir / 否
HY-R03460 mmu-miR-669c-3p mimic / 否
HY-R03460A mmu-miR-669c-3p agomir / 否
HY-R04277 rno-miR-196c-3p mimic / 否
HY-R04277A rno-miR-196c-3p agomir / 否
HY-R04284 rno-miR-200c-3p mimic / 否
HY-R04284A rno-miR-200c-3p agomir / 否
HY-R04468 rno-miR-449c-3p mimic / 否
HY-R04468A rno-miR-449c-3p agomir / 否
HY-R04484 rno-miR-466c-3p mimic / 否
HY-R04484A rno-miR-466c-3p agomir / 否
HY-RI00006 hsa-let-7c-3p inhibitor / 否
HY-RI00006A hsa-let-7c-3p antagomir / 否
HY-RI00333 hsa-miR-181c-3p inhibitor / 否
HY-RI00333A hsa-miR-181c-3p antagomir / 否
HY-RI00407A hsa-miR-200c-3p antagomir / 否
HY-RI00717 hsa-miR-34c-3p inhibitor / 否
HY-RI00717A hsa-miR-34c-3p antagomir / 否
HY-RI00832 hsa-miR-374c-3p inhibitor / 否
HY-RI00832A hsa-miR-374c-3p antagomir / 否
HY-RI00840A hsa-miR-376c-3p antagomir / 否
HY-RI01112 hsa-miR-449c-3p inhibitor / 否
HY-RI01112A hsa-miR-449c-3p antagomir / 否
HY-RI01546 hsa-miR-513c-3p inhibitor / 否
HY-RI01546A hsa-miR-513c-3p antagomir / 否
HY-RI01568 hsa-miR-518c-3p inhibitor / 否
HY-RI01568A hsa-miR-518c-3p antagomir / 否
HY-RI01590 hsa-miR-519c-3p inhibitor / 否
HY-RI01590A hsa-miR-519c-3p antagomir / 否
HY-RI01598 hsa-miR-520c-3p inhibitor / 否
HY-RI01598A hsa-miR-520c-3p antagomir / 否
HY-RI01678 hsa-miR-548c-3p inhibitor / 否
HY-RI01678A hsa-miR-548c-3p antagomir / 否
HY-RI02506 hsa-miR-892c-3p inhibitor / 否
HY-RI02506A hsa-miR-892c-3p antagomir / 否
HY-RI02698 mmu-miR-181c-3p inhibitor / 否
HY-RI02698A mmu-miR-181c-3p antagomir / 否
HY-RI02795 mmu-miR-1970c-3p inhibitor / 否
HY-RI02795A mmu-miR-1970c-3p antagomir / 否
HY-RI02833 mmu-miR-216c-3p inhibitor / 否
HY-RI02833A mmu-miR-216c-3p antagomir / 否
HY-RI02840 mmu-miR-219c-3p inhibitor / 否
HY-RI02840A mmu-miR-219c-3p antagomir / 否
HY-RI02897 mmu-miR-302c-3p inhibitor / 否
HY-RI02897A mmu-miR-302c-3p antagomir / 否
HY-RI03043 mmu-miR-344c-3p inhibitor / 否
HY-RI03043A mmu-miR-344c-3p antagomir / 否
HY-RI03077 mmu-miR-34c-3p inhibitor / 否
HY-RI03077A mmu-miR-34c-3p antagomir / 否
HY-RI03104 mmu-miR-374c-3p inhibitor / 否
HY-RI03104A mmu-miR-374c-3p antagomir / 否
HY-RI03111 mmu-miR-376c-3p inhibitor / 否
HY-RI03111A mmu-miR-376c-3p antagomir / 否
HY-RI03148 mmu-miR-449c-3p inhibitor / 否
HY-RI03148A mmu-miR-449c-3p antagomir / 否
HY-RI03198 mmu-miR-467c-3p inhibitor / 否
HY-RI03198A mmu-miR-467c-3p antagomir / 否
HY-RI03460 mmu-miR-669c-3p inhibitor / 否
HY-RI03460A mmu-miR-669c-3p antagomir / 否
HY-RI04277 rno-miR-196c-3p inhibitor / 否
HY-RI04277A rno-miR-196c-3p antagomir / 否
HY-RI04284 rno-miR-200c-3p inhibitor / 否
HY-RI04284A rno-miR-200c-3p antagomir / 否
HY-RI04468 rno-miR-449c-3p inhibitor / 否
HY-RI04468A rno-miR-449c-3p antagomir / 否
HY-RI04484 rno-miR-466c-3p inhibitor / 否
HY-RI04484A rno-miR-466c-3p antagomir / 否
HY-RS00536 AKR1C3 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01743 C3 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01744 C3AR1 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS05969 H3C3 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS05976 H4C3 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10520 PIK3C3 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10521 Pik3c3 Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS10522 Pik3c3 Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-W007376S Indole-3-carboxaldehyde-13C / 否
HY-W007798S Fmoc-Cys(Trt)-OH-1,2,3-13C3,15N / 否
HY-W007928S 1-O-Acetyl 2,3,5-tri-O-benzoyl-beta-D-ribofuranoside-13C / 否
HY-W007941S Fmoc-Ser(tBu)-OH-13C3,15N / 否
HY-W009204S4 Fmoc-Ala-OH-13C3,15N / 否
HY-W009204S5 Fmoc-Ala-OH-13C3 Modulator / 否
HY-W010407S2 Cyanuric acid-13C3,15N3 / 否
HY-W010575S (2R)-3-Amino-2-fluoropropanoic acid-13C3 / 否
HY-W011683S2 2'-Deoxyadenosine monohydrate-3′-13C / 否
HY-W013061S1 Propane-1,2,3-triyl tripalmitate-13C3 / 否
HY-W013061S4 Propane-1,2,3-triyl tripalmitate-13C3-1 / 否
HY-W015084S β-Ionone-13C3 Inducer / 否
HY-W015824S2 DL-Aspartic acid-3-13C / 否
HY-W017529S 6-Chloro-1,3,5-triazine-2,4-diamine-13C3 / 否
HY-W018386S 3-​Bromo-​L-​tyrosine-13C6 / 否
HY-W018386S1 3-​Bromo-​L-​tyrosine-13C9 / 否
HY-W018772S4 D-Ribose-13C-3 / 否
HY-W020044S DL-alpha-Tocopherol-13C3 Inhibitor / 否
HY-W040047S Pregnanediol 3-glucuronide-13C5 / 否
HY-W040240S1 (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-1 / 否
HY-W040240S2 (3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-2 / 否
HY-W041171S 3-Chloro-L-tyrosine-13C6 / 否
HY-W091039S N-Acetyl-α-neuraminic acid-13C3 / 否
HY-W096151 Chloroacetamido-C-PEG3-C3-NHBoc / 否
HY-W099927 [C3MPr]NTf2 / 否
HY-W127393 N-Nonanoyl-L-homoserine lactone / 否
HY-W127487 N-Octadecanoyl-L-homoserine lactone / 否
HY-W269693S 5-(4-Hydroxyphenyl)-5-phenylimidazolidine-2,4-dione-d5,13C3 / 否
HY-W324220 11β-HSD1-IN-10 / 否
HY-W357090S L-Idose-13C-3 / 否
HY-W584535 VH032-C3-Boc / 否
HY-W585905 Trimethylammonium chloride-13C3 / 否
HY-W653989 Desonide-13C3 / 否
HY-W753983 Pyruvic acid-13C3 / 否
HY-Y0418S3 Dulcite-13C-3 / 否
HY-Y0504S Trimethylammonium chloride-13c3,d9 / 否
HY-Y0721S 3-Bromofluorobenzene-13C6 / 否
HY-Y0921S3 (±)-1,2-Propanediol-13C3 / 否
HY-Y1117S1 Melamine-13C3 / 否
HY-Y1117S2 Melamine-15N3,13C3 / 否
HY-Y1662 D-Aminoacylase / 否
HY-10002S Calcitriol-13C3 Inhibitor ≥97.0% 否
HY-100840 (S)-4C3HPG / 否
HY-100840A (RS)-4C3HPG Antagonist / 否
HY-105414 Esterbut-3 / 否
HY-105969 Dichloromethotrexate / 否
HY-113294S 3-Hydroxykynurenine-13C3,15N 98.74% 否
HY-116170 SN34037 / 否
HY-118329 S 135 / 否
HY-118645S1 1'-Hydroxymidazolam-13C3 / 否
HY-120157 Vif-ElonginC interaction inhibitor 1 Inhibitor / 否
HY-121656 AKR1C2/3-IN-2 / 否
HY-122585 proMMP-9 inhibitor-3c Inhibitor / 否
HY-137225 HTS07944 / 否
HY-139227 Thalidomide 4'-oxyacetamide-C1-PEG3-C3-amine hydrochloride Inducer / 否
HY-144344S Benzyl(2R)-3-N,N-dibenzylamino-2-fluoropropanoate-13C3 / 否
HY-149560 Thalidomide-5-O-C3-NH2 hydrochloride 99.08% 否
HY-150532S (Rac)-Vitamin B5,Calcium Salt Hydrate-13C3 15N / 否
HY-151997S 1,2-Dioleoyl-3-lauroyl-rac-glycerol-13C3 / 否
HY-153539 AP-C3 Inhibitor / 否
HY-153540 AP-C4 Inhibitor / 否
HY-154746S 3-HPMA Potassium Salt-3-13C3,15N / 否
HY-154814S Monohydroxy-3-butenyl-mercapturic acid-13C3,15N sodium / 否
HY-156326S (3E,5E)-Octadien-2-one-13C2 / 否
HY-156326S1 (3E,5Z)-Octadien-2-one-13C2 / 否
HY-158861 C3-K2-E14 / 否
HY-158994S MEGDSRGG-(Ala-13C3,15N)-GGEA-(Leu-13C6,15N)-DPESAASSLSGAS TFA / 否
HY-159145 Lenalidomide-acetylene-C3-MsO / 否
HY-161652 Thalidomide-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione / 否
HY-161656 PIP-C-3-Azaspiro[5.5]undecane-boc / 否
HY-163032 FABP4-IN-3 Inhibitor / 否
HY-163647 Lenalidomide-COCH-PEG2-azido / 否
HY-168192 Thalidomide-NH-C4-amide-C3-Br / 否
HY-B0111RS Drospirenone-13C3 / 否
HY-B0710S Betaine-13C3 / 否
HY-B1804S Tricaprilin-13C3 / 否
HY-N0092S4 Inosine-13C3 / 否
HY-N0368S1 Linalool-13C3 / 否
HY-N0803S1 Myrcene-13C3 Inhibitor / 否
HY-N1071 Wilforol C / 否
HY-N12816 Glaucogenin C 3-O-α-L-cymaropyranosyl-(1→4)–β-D-digitoxopyranosyl-(1→4)-β-D-canaropyranoside / 否
HY-N1849 3'-Methoxyrocaglamide / 否
HY-N2355 Solasurine / 否
HY-N7092S22 D-Fructose-13C3 / 否
HY-N7092S23 D-Fructose-13C3-1 / 否
HY-N9522 β-D-glucopyranosyl-[α-L-rhamnopyranosyl-(1→3)-βD-glucuronopyranosyl-(1→3)]-3β-hydroxyolean-12-ene28-oate 99.95% 否
HY-W012578S1 2-Isopropyl-3-methoxypyrazine-13C3 / 否
HY-W012932S 2,4-Dimethylthiazole-13C3 / 否
HY-W046063 O-Phthalimide-C3-acid / 否
HY-W145482S1 3-O-Methyl-D-glucopyranose-13C6 / 否
HY-W156840S OTNE-13C3 / 否
HY-W585956 Triclocarban-13C6 / 否
HY-W654120 Creatine-13C3 / 否
HY-W654362 (R)-2-Thioxothiazolidine-4-carboxylic acid-13C3 / 否
HY-W751098 Aldosterone-13C3 / 否
HY-W751099 Corticosterone-13C3 / 否
HY-W769714 Favipiravir-13C3 Inhibitor / 否
HY-W770183 Uric acid-13C3 / 否
HY-W778140 Diethyl phosphate-13C4 sodium Inhibitor / 否
HY-111843 Ch55-O-C3-NH2 / 否
抗体抑制剂 (1)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P99905 Efdamrofusp alfa / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens C3 NCBI NCBI:718
Canis familiaris C3 NCBI NCBI:476728
Mus musculus C3 NCBI NCBI:12266
Rattus norvegicus C3 NCBI NCBI:24232
Macaca mulatta C3 NCBI NCBI:703613
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z